skip to content »

Validating test questions

validating test questions-9

Either test is intended to accurately reflect the purity characteristics of the sample.Different validation characteristics are required for a quantitative test than for a limit test.

validating test questions-89

Establishing that a test method consistently produces reliable analytical results is a critical element of assuring the quality and safety of pharmaceutical products.Laboratories that make method validation a part of standard operating procedures provide themselves a clear means of successful continued support of drug development and production activities. A: The extent of testing for a given method is driven by its intended purpose.A test for appearance will not require the same validation experiments and supporting data as a chromatographic assay.These serve to establish the method ruggedness or robustness.Test method validation is a requirement for entities engaging in the testing of biological samples and pharmaceutical products for the purpose of drug exploration, development, and manufacture for human use.Changes in equipment, solution composition, quantitation range, or sample preparation merit partial method validation.

Fewer validation tests are generally needed compared to a full validation; they are selected based on the potential effects of the new changes on method performance and data integrity.

This includes bioanalytical methods of analysis for bioavailability (BA), bioequivalence (BE), pharmacokinetic (PK), toxicokinetic (TK), and clinical studies, as well as methods used for analytical testing of manufactured drug substances and products.

According to ICH Guidelines, the following four types of methods require validation: In addition, ICH Guidelines define these four types of methods: “Identification tests are intended to ensure the identity of an analyte in a sample.

Assay procedures are intended to measure the analyte present in a given sample.

In the context of this document, the assay represents a quantitative measurement of the major component(s) in the drug substance.

This is normally achieved by comparison of a property of the sample (e.g., spectrum, chromatographic behavior, chemical reactivity, etc.) to that of a reference standard.